Public Engagement,
Molecular Targets and Therapeutics,
MCD,
Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research
The CureGPX4 Foundation has named Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, as the first recipient of the Raghav Prize for Rare Disease and Citizen Science. The prize recognizes his research into…
